In the rapidly evolving realm of digital health, ensuring that innovative technologies are both safe and effective is paramount. For digital health manufacturers, understanding and navigating the assessment frameworks that …
Odelle Technology
-
News
-
As we mark Breast Cancer Awareness Month, it’s vital to highlight the progress being made in the tools we use to diagnose and treat this complex disease. Among the latest innovations …
-
In Spain, getting in vitro diagnostics (IVDs) reimbursed involves navigating distinct pathways, each with its focus and requirements. The three primary systems are theSpanish Catalogue of Health Products, the Common …
-
News
GSK Invests £50 Million into a Groundbreaking Partnership with Cambridge: Tackling Immune-Related Diseases
GSK is taking a bold step forward in the fight against immune-related diseases by investing £50 million into a new five-year collaboration with the University of Cambridge and Cambridge University Hospitals. Dubbed the Cambridge-GSK Translational …
-
Roche Diagnostics has reached a major milestone as the World Health Organisation (WHO) has granted pre-qualification to its cobas® HPV test for use on the cobas 5800, 6800, and 8800 systems, including for …
-
The structure of roles and responsibilities under the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) brings together a blend of EU-level regulation and local oversight. This balance ensures that while …
-
The NHS Work Programme plays a vital role in ensuring patients across the UK gain access to innovative and effective treatments. Through a rigorous evaluation process, the Clinical Priorities Advisory …
-
Regulatory Pathway for Companion Diagnostics in France In France, companion diagnostics (CDx) are subject to a thorough regulatory and reimbursement process, primarily led by the Haute Autorité de Santé (HAS). …
-
Companion diagnostic (CDx) is evaluated and listed in the EBM (Einheitlicher Bewertungsmaßstab) catalogue in Germany, let’s enrich the discussion around each step, focusing on specific mechanisms, scientific rationale, and real-world examples. Here’s a …
-
News
Evidence Requirements for Medical Device Reimbursement in France: An Analysis of the LPPR 2024 Guidelines
The French healthcare system is well-regarded for its extensive coverage and robust framework for evaluating and reimbursing medical devices. At the heart of this system is the Liste des Produits …